Latest Insider Transactions at Nkarta, Inc. (NKTX)
This section provides a real-time view of insider transactions for Nkarta, Inc. (NKTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nkarta, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nkarta, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 13
2023
|
Nadir Mahmood President |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+30.51%
|
-
|
|
Jan 13
2023
|
David Shook |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+38.27%
|
-
|
|
Jan 13
2023
|
James Trager Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+27.34%
|
-
|
|
Jan 13
2023
|
Ralph Brandenberger Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+42.17%
|
-
|
|
Jan 13
2023
|
Alicia J. Hager Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+39.14%
|
-
|
|
Jan 13
2023
|
Paul J Hastings Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,500
+16.92%
|
-
|
|
Oct 06
2022
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
842
-9.74%
|
$11,788
$14.02 P/Share
|
|
Oct 06
2022
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
842
+8.88%
|
$2,526
$3.89 P/Share
|
|
Sep 29
2022
|
Paul J Hastings Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
498
-0.2%
|
$6,474
$13.0 P/Share
|
|
Sep 28
2022
|
Paul J Hastings Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,376
-8.52%
|
$303,888
$13.03 P/Share
|
|
Sep 21
2022
|
Paul J Hastings Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,126
-2.18%
|
$79,638
$13.01 P/Share
|
|
Aug 15
2022
|
James Trager Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.44%
|
$85,000
$17.53 P/Share
|
|
Aug 15
2022
|
James Trager Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.93%
|
$15,000
$3.89 P/Share
|
|
Aug 15
2022
|
Nadir Mahmood President |
SELL
Open market or private sale
|
Direct |
7,500
-14.0%
|
$135,000
$18.03 P/Share
|
|
Aug 15
2022
|
Nadir Mahmood President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+12.28%
|
$22,500
$3.89 P/Share
|
|
Aug 15
2022
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
11,000
-58.51%
|
$187,000
$17.64 P/Share
|
|
Aug 15
2022
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+36.91%
|
$33,000
$3.89 P/Share
|
|
Aug 08
2022
|
Nadir Mahmood President |
SELL
Open market or private sale
|
Direct |
7,500
-14.0%
|
$112,500
$15.32 P/Share
|
|
Aug 08
2022
|
Nadir Mahmood President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+12.28%
|
$22,500
$3.89 P/Share
|
|
Aug 08
2022
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
11,593
-59.78%
|
$173,895
$15.51 P/Share
|
|
Aug 08
2022
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,593
+18.23%
|
$34,779
$3.02 P/Share
|
|
Jul 25
2022
|
Nadir Mahmood President |
SELL
Open market or private sale
|
Direct |
7,500
-14.0%
|
$97,500
$13.4 P/Share
|
|
Jul 25
2022
|
Nadir Mahmood President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+12.28%
|
$22,500
$3.89 P/Share
|
|
Jul 25
2022
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
3,000
-27.78%
|
$39,000
$13.41 P/Share
|
|
Jul 25
2022
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+21.74%
|
$0
$0.41 P/Share
|
|
Jun 17
2022
|
Ralph Brandenberger Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+24.27%
|
-
|
|
Jun 17
2022
|
James Trager Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+7.44%
|
-
|
|
Jun 17
2022
|
Alicia J. Hager Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+27.78%
|
-
|
|
Jun 17
2022
|
Nadir Mahmood President |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+11.52%
|
-
|
|
Jun 17
2022
|
Paul J Hastings Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+6.5%
|
-
|
|
Jun 03
2022
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
4,140
-43.86%
|
$62,100
$15.0 P/Share
|
|
Jun 03
2022
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,140
+11.3%
|
$12,420
$3.24 P/Share
|
|
Apr 28
2022
|
Simeon George |
BUY
Open market or private purchase
|
Indirect |
1,333,333
+50.0%
|
$19,999,995
$15.0 P/Share
|
|
Apr 26
2022
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,200,000
+21.99%
|
$33,000,000
$15.0 P/Share
|
|
Jan 14
2022
|
Ralph Brandenberger Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,300
+50.0%
|
-
|
|
Jan 14
2022
|
James Trager Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+18.29%
|
-
|
|
Jan 14
2022
|
Alicia J. Hager Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+50.0%
|
-
|
|
Jan 14
2022
|
Kanya Rajangam Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+50.0%
|
-
|
|
Jan 14
2022
|
Nadir Mahmood President |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+24.2%
|
-
|
|
Jan 14
2022
|
Paul J Hastings Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,900
+13.83%
|
-
|
|
Dec 01
2021
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
4,140
-100.0%
|
$62,100
$15.64 P/Share
|
|
Dec 01
2021
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,140
+39.36%
|
$12,420
$3.24 P/Share
|
|
Sep 29
2021
|
Paul J Hastings Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.87%
|
$221,000
$26.87 P/Share
|
|
Sep 01
2021
|
Ralph Brandenberger Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
4,140
-100.0%
|
$132,480
$32.08 P/Share
|
|
Sep 01
2021
|
Ralph Brandenberger Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,140
+39.36%
|
$12,420
$3.24 P/Share
|
|
Aug 05
2021
|
Kanya Rajangam Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$370,000
$37.28 P/Share
|
|
Aug 05
2021
|
Kanya Rajangam Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.41 P/Share
|
|
Aug 02
2021
|
James Trager Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,600
-7.5%
|
$111,600
$31.53 P/Share
|
|
Aug 02
2021
|
James Trager Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+4.48%
|
$6,750
$3.89 P/Share
|
|
Jul 01
2021
|
Nadir Mahmood President |
SELL
Open market or private sale
|
Direct |
6,500
-19.24%
|
$201,500
$31.71 P/Share
|